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Although a variety of nanoparticles (NPs) functionalized with amphotericin B, an antifungal agent widely
used in the clinic, have been studied in the last years their cytotoxicity proﬁle remains elusive. Here we
show that human endothelial cells take up high amounts of silica nanoparticles (SNPs) conjugated with
amphotericin B (AmB) (SNP-AmB) (65.4  12.4 pg of Si per cell) through macropinocytosis while human
ﬁbroblasts internalize relatively low amounts (2.3  0.4 pg of Si per cell) because of their low capacity for
macropinocytosis. We further show that concentrations of SNP-AmB and SNP up to 400 mg/mL do not
substantially affect ﬁbroblasts. In contrast, endothelial cells are sensitive to low concentrations of NPs
(above 10 mg/mL), in particular to SNP-AmB. This is because of their capacity to internalize high con-
centration of NPs and high sensitivity of their membrane to the effects of AmB. Low-moderate con-
centrations of SNP-AmB (up to 100 mg/mL) induce the production of reactive oxygen species (ROS), LDH
release, high expression of pro-inﬂammatory cytokines and chemokines (IL-8, IL-6, G-CSF, CCL4, IL-1b
and CSF2) and high expression of heat shock proteins (HSPs) at gene and protein levels. High concen-
trations of SNP-AmB (above 100 mg/mL) disturb membrane integrity and kill rapidly human cells
(60% after 5 h). This effect is higher in SNP-AmB than in SNP.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
AmB is a potent antifungal agent, approved by the FDA, widely
used in clinical practice and effective against a large spectrum of
fungi. Few resistant strains of fungi to AmB have been reported so
far [1]. Experimental data indicates that AmB associates with the
ergosterol in the fungal cell membrane, forming pores and conse-
quently disrupting the ionic gradient [2]. Due to these properties,
AmB has been permanently immobilized in hydrogels [3,4] and
nanomaterials (silica and carbon nanotubes) [5e7]. The nano-
formulations have been used to create permanent coatings [7]
and as substitutes of commercial lipid-based nanoformulations of
AmB [5,6]. The competitive advantages of AmB immobilized ontovation Center, Núcleo 4, Lote
ted equally to this work.
All rights reserved.nanomaterials relatively to lipid-based formulations are ascribed
to (i) increased stability of the AmB nanomaterial conjugate,
(ii) potential decrease in the concentration required for therapeutic
use (due to the immobilization of high doses of agent at the surface
of the nanomaterial), and (iii) the possibility of incorporating
ligands to target speciﬁc tissues. Unfortunately, it is relatively un-
known the cytotoxic proﬁle of AmB nanomaterials conjugates.
Previous studies have shown that cellular toxicity of AmB was
higher when associated with low-density lipoprotein (LDL) [8,9].
However, it is unclear whether the toxicity effect is mediated by an
interaction of AmBwith cell membrane or requires the intracellular
delivery of AmB. Further, although several experimental results
indicate that the toxicity of AmB is due to its ability to induce
oxidative stress and disturb normal ion functioning [2,10,11], it is
unclear whether both mechanisms occur at the same time or are
dependent on the concentrations of AmB.
In this work, we hypothesize that the cytotoxic effect of AmB is
dependent on cell type and it depends on the initial concentration
of the NPs. To verify this hypothesis we have evaluated the
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bilical vein endothelial cells (HUVECs) and ﬁbroblasts. We have
studied the uptake mechanism and intracellular fate of the NPs
with andwithout AmB and their effect in cell metabolic activity and
proliferation. Further, we have quantiﬁed cell membrane integrity,
oxidative stress, and apoptosis on cells treated with SNPs with and
without AmB. Finally, we have quantiﬁed the expression of stress
and toxicity genes and quantiﬁed the secretion of cytokines.
2. Materials and methods
2.1. Conjugation of SNPs with DexOx and DexOxAmB
SNP5 were kindly offered by Eka (Sweden), while SNP80 were purchased from
PlasmaChem GmbH (Germany). Either SNP5 or SNP80 used in the entire work were
from the same batch. The silanization, conjugation of AmB (AppliChem GmbH,
Germany) to the NPs and NPs characterizationwas performed according to protocols
previously reported by us [7]. Endotoxin levels in the nanoparticle suspension
(50 mg/mL) were detected using a Limulus assay kit (Lonza) and found to be
below 0.125 EU/mL, the acceptable levels of endotoxins for pharmaceutical formu-
lations [12].
2.2. Cell culture
Primary human skin ﬁbroblasts (Lonza) were grown in DMEM supplemented
with 10% fetal bovine serum (FBS), at 37 C in a fully humidiﬁed air containing 5%
CO2. The cells were fed every 2e3 days. HUVECs (Lonza) were cultured in EGM-2
media (Lonza; containing 2% of FBS) being the medium replaced every 2 days.
Both cells were passaged after reaching 80% conﬂuency. Cells between the 3rd and
7th passages were used in the entire work.
2.3. NP uptake by FACS analysis
Fluorescent-labeled SNPs were obtained by reacting DexOx or DexOxAmB with
ﬂuoresceinamine or by reacting the terminal amine groups in SNPs with ﬂuorescein
isothiocyanate (FITC). In the ﬁrst case, DexOx (250 mg) was reacted with ﬂour-
esceinamine (26.7 mg) in a 1:1 mixture of 0.01 M borate buffer pH 10 with DMSO
(12 mL). The reaction was allowed to proceed for 18 h and the conjugate was then
dialyzed against distilled water in a 6e8 kDa MWCO membrane for 2 days. The
conjugates were then freeze-dried. Fluorescent DexOxAmB was prepared in a
similar manner, being AmB (213 mg) added to the reaction mix. To prepare ﬂuo-
rescent SNPs (without DexOx or DexOxAmB), we reacted SNP5eNH2 (100 mg) with
FITC (19.5 mg) or SNP80eNH2 (100 mg) with FITC (24 mg) in 0.01 M borate buffer pH
10 (12.5 mL) with magnetic stirring for 18 h. Unbound FITC was removed by
centrifugation and washing of the NP with distilled water.
HUVECs or ﬁbroblasts were plated in gelatin-coated 24 well plates (1105 cells/
well). After 18 h, the cells were incubated with SNP5eNH2eFITC, SNP80eNH2eFITC,
SNP5eDexOx-ﬂuoresceinamine, SNP80eDexOx-ﬂuoresceinamine, SNP5eDexOx-
AmB-ﬂuoresceinamine or SNP80eDexOxAmB-ﬂuoresceinamine (all at 50 mg/mL)
suspended in cell culturemedium (i.e., DMEM supplementedwith 10% FBS in case of
ﬁbroblasts and EGM-2 containing 2% of FBS for HUVECs). After 5 or 24 h, the cells
were washed with PBS, dissociated with trypsin (0.2% w/v, in PBS) and treated with
an aqueous solution of trypan blue (0.4%, w/v) in order to quench the ﬂuorescence of
NPs that were not taken up by the cells [13]. Samples were then washed twice
(300 g, 2 min) with PBS and analyzed on a FACScalibur (Becton Dickison) using
CellQuest software.
For the tests in the presence of endocytosis inhibitors, HUVECwere seeded on 24
well plates (3104 cells/well) and left for 24 h before starting the test. The following
inhibitors were tested: ﬁlipin III (HUVEC: 5 mg/mL, ﬁbroblasts: 1 mg/mL, 30 min pre-
incubation), cytochalasin D (HUVEC: 1 mM, ﬁbroblasts: 0.5 mM, 120 min), nocodazole
(HUVEC: 30 mM, ﬁbroblasts: 10 mM, 30 min), polyinosinic acid (HUVEC: 100 mg/mL,
ﬁbroblasts: 10 mg/mL, 30 min) and dansylcadaverine (HUVEC: 100 mM, ﬁbroblasts:
50 mM, 30 min). The inhibitor concentrations were based in values reported in the
literature and further validate by us to have no cytotoxic effect over the period of the
assay (5 h), as conﬁrmed by us using a propidium iodide (PI) assay. When possible,
we further conﬁrmed that the concentration tested was active. For example, dan-
sylcadaverine (100 mM) was able to inhibit the internalization of transferrin-FITC
conjugate by clathrin-mediated endocytosis in HUVECs (Supplementary Fig. 2B).
After the pre-incubation with the inhibitor, SNP5eDexOx or SNP5eDexOxAmB
(50 mg/mL) formulations were added to the cells, maintaining the inhibitor con-
centration. As controls we used cells incubatedwithout NPs and cells incubatedwith
SNP5eDexOx or SNP5eDexOxAmB without inhibitor. After 5 h incubation with the
NPs wewashed the cells two times with DMEMwith 10% FBS and one time with PBS
before trypsinization. After trypsinization, the cells were centrifuged and the su-
pernatant removed. The cells were resuspended in PBS and kept on ice for imme-
diate analysis by ﬂow cytometry.2.4. Inductive coupled plasma mass spectrometry (ICP-MS) analysis
HUVECs (5  105 cells/well) and ﬁbroblasts (3.5  105 cells/ﬂask) were plated in
6 well plates and T75 ﬂasks, respectively, and left to adhere overnight. Then the cells
were incubated with SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL) for 5 or 24 h.
After incubation, in order to remove non-internalized NPs, the cells were washed
three times with PBS, dissociated with trypsin [0.2% (w/v) in PBS], centrifuged,
counted and washed againwith PBS. Afterwards, the samples were freeze-dried and
the presence of silicon in the samples was evaluated by ICP-MS according to a
previous protocol [14]. For this purpose, the samples were digested overnight in the
presence of hydroﬂuoric acid (0.1 mL, 40%, (w/v)) and ultrasounds. Then, aqueous
nitric acid solution (9.9 mL, 2% (w/v)) was added. The samples (n¼ 3) were analyzed
by ICP-MS for the quantiﬁcation of internalized silicon.
2.5. Cellular uptake of NPs by confocal microscopy
HUVECs were plated on a gelatin-coatedmicroscope slide (m-Slide Angiogenesis,
Ibidi, Germany) (1  104 cells/well) and ﬁbroblasts were plated on 24-well plates
(5  104 cells/well) and left to adhere overnight before adding SNP5eNH2eFITC,
SNP80eNH2eFITC, SNP5eDexOx-ﬂuoresceinamine, SNP80eDexOx-ﬂuorescein-
amine, SNP5eDexOxAmB-ﬂuoresceinamine or SNP80eDexOxAmB-ﬂuorescein-
amine (all at 50 mg/mL) in EGM-2 (HUVECs) or DMEM with 0.5% (v/v) Pen Strep
(ﬁbroblasts). After 5 or 24 h, ﬁbroblasts were washed with PBS, harvested with
trypsin and plated on coverslips coated with gelatin. HUVEC were washed three
times 5 min with DMEM with 10% FBS. Endosomes were stained with Lysotracker
Red DND-99 (Invitrogen, 1:20 000 in medium) for 20 min, at 37 C, following the
recommendations of the dye manufacturer. Then, cells were ﬁxed with para-
formaldehyde (4% (v/v)) for 10 min, at room temperature, and washed two times
with PBS. After blocking (PBS solution having 2% BSA and 2% FCS) for 30 min,
HUVECs were incubated with mouse anti-human CD31 antibody (Dako, dilution
1:50) for 60 min, washed two times with PBS and incubated with Dylight 649
conjugated donkey anti-mouse IgG (BioPortugal, dilution 1:200) for 60 min. Un-
bound antibody was removed by washing two times with PBS before staining with
DAPI (Sigma, 2 mg/mL in PBS) for 10 min. Coverslips were mounted and analyzed by
confocal microscopy.
2.6. Transmission electron microscopy analyses
HUVECs were exposed to SNP5eNH2, SNP5eDexOx or SNP5eDexOxAmB at
50 mg/mL for 24 h. After incubation, cells were washed three times with EGM-2
medium and ﬁxed with glutaraldehyde (2.5%, v/v, in cacodylate buffer). Secondary
ﬁxations were made in OsO4 (1%, v/v, in cacodylate buffer) and in uranyl acetate
(0.5%, v/v, in acetate-acetic acid buffer). The samples were then dehydrated and
embedded in Epon-Araldite. Thin sections (79e90 mm) of the samples were then
analyzed by TEM (JEOL 100SX).
2.7. Cytotoxicity of SNPs functionalized with DexOxAmB
Cells (1104 cells/well) were seeded onto a 96-well plate coated with 0.1% (w/v)
gelatin and left to adhere. The cells were then incubated with NPs (from 10 to 500 mg/
mL) for 5 h or 24 h. In some cases (LDH assay), the medium was then collected and
centrifuged 5 min at 250 g to remove NP aggregates and cell debris and then the LDH
content of the samples (n ¼ 6) was determined using colorimetric assay (TOX-7 kit,
Sigma). As negative control we used the medium of cells incubated without NPs. For
the positive control we removed the medium (200 mL) and added Triton X-100 so-
lution (20 mL, 0.5% in water) to the cells. After observing total cell lysis, we added
180 mL of the initial medium to the well. We analyzed the medium according to
manufacturer’s instructions. In other cases, the cells were washed and ATP produc-
tion measured by a Celltiter-Glo Luminescent Cell Viability Assay (Promega).
For Annexin V/PI assay, HUVECs (1 105 cells/well) were seeded onto a 24-well
plate coatedwith 0.1% (w/v) gelatin and left to adhere. The cells were then incubated
with NPs (10e300 mg/mL) for 5 h or 24 h. After the incubation time, the medium
with the detached cells was collected and the adherent cells rinsed with PBS and
trypsinized. Both the detached cells and adherent cells were then mixed and the
cells were centrifuged for 3 min at 350 g. The cells were washed with PBS, resus-
pended in PBS (100 mL), and stained with annexin binding buffer (Invitrogen, 200 mL,
containing 2.5 mL of Annexin V-FITC conjugate). The cells were incubated in the dark
at room temperature for 10 min and then on ice before analysis in the ﬂow cy-
tometer. To stain the dead cells, PI (10 mL, 100 mg/mL) was added shortly before
running each sample (n ¼ 3).
2.8. Cell proliferation in the presence of SNP-DexOx and SNP-DexOxAmB
HUVECs or ﬁbroblasts were plated in gelatin-coated 24well plates (5104 cells/
well). After 18 h, the cells were incubated with SNP5eDexOx, SNP80-DexOx, SNP5e
DexOxAmB or SNP80-DexOxAmB at 50 or 100 mg/mL. After 24 h, the cells were
washed with PBS, harvested with trypsin (0.2% in PBS) and counted using a Neu-
bauer chamber. Cells without NPswere used as controls for cell number at initial and
ﬁnal incubation times. Each condition was done in triplicate.
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HUVECs (1  105 cells/well) were seeded onto a 24-well plate coated with 0.1%
(w/v) gelatin and left to adhere. The cells were then incubated with NPs (10e300 mg/
mL) for 12 or 24 h. After the incubation time, the mediumwas collected and kept at
4 C. In themeantime, the adherent cells were rinsedwith PBS and then incubated in
serum free medium (Medium 200, Gibco) containing the oxidation-sensitive probe
carboxy-H2DCFDA (10 mM) for 1 h to load the dye in the cells. After this, the serum
free medium was replaced with complete medium and the cells were allowed to
recover for 2 h. Then, the cells were trypsinized and the mediumwith the dead cells
was added. Cells were centrifuged for 3 min at 350 g, resuspended in PBS (200 mL)
and kept on ice before analysis in the ﬂow cytometer. To stain the dead cells, PI
(10 mL, 100 mg/mL) was added shortly before running each sample (n ¼ 3). As
negative control we used cells incubated without NP or with SNP5eDexOx.
2.10. Real-time RT-PCR array
HUVECs were seeded in 6-well plates (1.5  106 distributed by 3 wells) and
incubated for 24 h with SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL). Cells
without NPs were used as control. After incubation, cells were trypsinized and total
RNA was isolated using a protocol with TRIzol (Invitrogen) and RNeasy Minikit
(Qiagen, Valencia). cDNAwas prepared from 1 mg total RNA using the RT2 PCR Array
ﬁrst strand kit (SABiosciences), according to the manufacturer’s instructions. RT-PCR
assays were performed using the human stress and toxicity pathway ﬁnder RT-PCR
array (SA Biosciences) on an ABI PRISM 7500 System. Data analysis was performed
using analysis software provided by the kit manufacturer.
2.11. Cytokine secretion analyses
HUVECs and ﬁbroblasts were incubated with medium containing SNP5eDexOx
or SNP5eDexOxAmB (50 mg/mL) for 5 or 24 h. The media was then collected and
centrifuged to remove potential cells and NPs. Supernatants were evaluated for the
presence and concentrations of cytokines using a Bio-Plex Pro Human Cytokine 17-
Plex Panel Assay (Bio-Rad, Hercules, CA, USA) according to manufacturer’s in-
structions, in a Bio-Plex 200 System (Bio-Rad). The human Group I 17-Plex Panel
consisted of the following analytes: interleukin-1b (IL-1b), IL-2, IL-4, IL-5, IL-6, IL-7,
IL-8; IL-10, IL-12(p70), IL-13, IL-17, granulocyte colony-stimulating factor (G-CSF),
granulocyte/macrophage colony-stimulating factor (GM-CSF), interferon-g (IFN-g),
monocyte chemotactic protein monocyte chemotactic activating factor [MCP-1
(MCAF)], macrophage inﬂammatory protein-b (MIP-1 b) and tumor necrosis fac-
tor-a (TNF-a). A standard range of 0.2e3200 pg/mL was used. Samples and controls
were run in triplicate, standards and blanks in duplicate.
2.12. Characterization of HSP70 cellular localization by confocal microscopy
Round glass coverslips were sterilized with 100% ethanol and UV radiation for
30 min. Then, they were dried, placed in wells of a 24-well plate and coated with
0.1% (w/v) gelatin. HUVEC (1  105 cells/well) were seeded on the coverslips and
allowed to adhere. Cells were incubated with SNP5eDexOx or SNP5eDexOxAmB
(50 mg/mL) for 5 and 24 h. Cells incubated without NPs or cells incubated for 3 h at
42.5 C were used as negative and positive controls, respectively. Cells were washed,
ﬁxed with 4% (v/v) paraformaldehyde in PBS for 15 min at room temperature, and
then washed two times with cold PBS. Permeabilization of the cells was done by
incubating 10 min with PBS containing 0.25% Triton X-100. The detergent was
removed by washing three times with PBS. Before staining, unspeciﬁc binding sites
were blocked with PBS containing 1% BSA and 0.3 M glycine for 30 min. The cells
were then incubated with mouse anti-human HSP70 (3A3) antibody (sc-32239,
Santa Cruz) (1:50 in PBS containing 1% BSA) for 1 h at room temperature. Cells were
washed three times with PBS and then incubated for 1 h in the dark with goat anti-
mouse IgG Cy3 conjugate (Sigma; 1:50 dilution in PBS containing 1% BSA). Cells were
washed three times with PBS and nuclei were stained with DAPI (1 mg/mL) for 5 min.
2.13. Quantiﬁcation of total HSP70 protein expression by sandwich ELISA
HUVEC were seeded on to 6-well plates (2  105 cells/well) coated with 0.1%
(w/v) gelatin and left to adhere and grow until 80% conﬂuency (approximately
8  105 cells/well). Cells were incubated with NPs (50 mg/mL) for 5 and 24 h. For
negative control we used cells incubated without NPs and as positive control cells
submitted to heat shock (42.5 C, 3 h). The cells were then rinsed two times with
PBS, placed on ice, and lysis buffer (200 mL containing 1 mM EDTA, 0.5% Triton X-100,
10 mg/mL Leupeptin, 10 mg/mL Pepstatin, 100 mg/mL PMSF, 3 mg/mL Aprotinin in PBS,
pH 7.4) was added to the cells, which were detached from the plate using cell
scrapers. The cell lysates (n ¼ 3) were analyzed using the DuoSet IC Intracellular
ELISA kit for total HSP70 (R&D Systems) to obtain the amount of HSP70 protein per
sample. The results were normalized to the total cell number per sample. This was
done by a total DNA quantiﬁcation in the lysates. We prepared cell lysates from
known cell numbers to use as standards. The quantiﬁcation of DNA was performed
using Hoechst dye (2 mg/mL in TNE Buffer (10 mM Tris pH 7.5, 0.1M NaCl, 10 mM
EDTA)). The Hoechst solutionwas pipetted into wells of a black 96-well plate (95 mL/well) and 5 mL of standard or sample lysate was added to each well. The plates were
read immediately on a Spectra Max Gemini EM microplate reader (Molecular
Devices).
3. Results and discussion
3.1. Properties of NPs
AmBwasconjugated to SNPshavingan initial diameterof 5 (SNP5)
and 80nm (SNP80) (Fig.1A). Initially, SNP5 and SNP80were silanized
with amine-containing silane compounds (see Materials and
methods; named SNP80eNH2 and SNP5eNH2) [7]. AmB was immo-
bilized covalently to oxidized dextran (DexOx) by its amine group.
Previously, we [7] and others [15] have shown that AmB immobilized
by its amine group is still active. The conjugation of AmB to DexOx
improves the solubility of AmB in aqueous solutions and facilitates its
immobilization onto SNPs. Then, DexOxAmB (12 mg/mL) with a de-
gree of AmB incorporation of 15%was reactedwith SNPs. The content
of DexOxAmB conjugate immobilized on the surface of NPs was
determined by the anthrone assay [7,16]. The diameter, net charge,
concentration of AmB per mg of SNPs, and minimum inhibitory
concentrations (MIC) are summarized in Supplementary Table 1.
3.2. Internalization of NPs by HUVEC and human skin ﬁbroblasts
HUVECs and human ﬁbroblasts were chosen in this study as
representative models for the various cellular environments that
NPs may interact with. Endothelial cells represent a model for the
evaluation of NPs toxicity in the bloodstream. Fibroblasts represent
a model to evaluate the acute toxicity of the NPs released by the
biomedical devices. Initially, the uptake of different sets of ﬂuores-
cent SNPs by both cells was evaluated by ﬂow cytometry. Both type
of cells were exposed to NPs (50 mg/mL) for 5 h and 24 h in cell
medium containing serum (see Materials and methods). Under
these conditions NPs maintain their antifungal properties after in-
cubation in cell medium. HUVECs internalized efﬁciently all the NPs
tested, being approximately 100% of the cells labeled with NPs after
5 h (Fig. 1B.1). The internalization of the NPs in HUVECs was also
studied for incubation times below 5 h (Supplementary Fig.1 A). The
internalization kinetic of SNP5eDexOxAmB in HUVECs was signif-
icantly (P < 0.001 at 1 h) faster than SNP5eDexOx. Fibroblasts were
less prone to internalize NPs as compared to HUVECs (Fig. 1B.2).
Fibroblasts internalized with higher efﬁciency SNP5eNH2 (5 h:
82.2  0.8%; 24 h: 97.6  0.6%) and SNP5eDexOx (5 h: 8.6  3.2%;
24 h: 79.0  0.9%) than SNP5eDexOxAmB (5 h: 0.02  0.03%; 24 h:
67.2  2.8%). In addition, they internalized with higher efﬁciency
SNP80eNH2 (5 h: 49.5  0.4%; 24 h: 86.6  0.5%) and SNP80e
DexOxAmB (5 h: 0%; 24 h: 75.8 1.0%) than SNP80eDexOx (5 h: 0%;
24 h: 63.5 0.9%). Because no substantial differenceswere observed
in the uptake of SNP5 and SNP80 at the 24 h time point in both types
of cells, SNP5 formulation was used for subsequent studies.
To quantify the real amount of NPs internalized by each type of
cell, inductive coupled plasma mass spectrometry (ICP-MS) was
used (Fig. 1C). For these studies HUVECs and ﬁbroblasts were
exposed to SNP5eDexOx and SNP5eDexOxAmB (50 mg/mL) for 5 h
and 24 h. HUVECs internalized higher concentration of NPs (be-
tween 36.9  2.1 and 65.4  12.4 pg of Si per cell) than ﬁbroblasts
(between 0 and 2.3  0.4 pg of Si per cell). In case of HUVECs, the
amount of silicon uptake correlates directly with the time of cell
exposure to SNPs (Fig. 1C.1). The results indicate a time-dependent
increase in the uptake of the SNPs by HUVECs. Our results also show
that the conjugation of AmB to the NPs facilitated NP cellular
internalization at 24 h.
Very few studies have quantiﬁed the real concentration of SNPs
internalized by the cells [14]. Typically, the initial dose of NPs added
Fig. 1. Cellular uptake of NPs. A) Schematic representation of the methodology followed for the immobilization of AmB into NPs. B) Percentage of HUVECs (B.1) and ﬁbroblasts (B.2)
labeled with ﬂuorescent NPs after 5 and 24 h of incubation, as assessed by ﬂow cytometry. C) Quantiﬁcation of silicon in HUVECs (C.1) and human ﬁbroblasts (C.2) as determined by
ICP-MS analysis. Cells were incubated with SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL) for 5 or 24 h. After the incubation, the cells were washed, trypsinized and ﬁnally freeze-
dried. The concentration of silicon was normalized per cell. In B and C, the results are expressed as Mean  SEM (n ¼ 3). *denotes statistical signiﬁcance (P < 0.05).
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show that HUVECs have the ability to internalize higher concen-
trations of SNPs than ﬁbroblasts. The level of internalization ob-
tained for SNP5eDexOx is similar to the one previously reported forHUVECs (40 pg of silicon per cell) exposed for 24 h to a suspension
of SNPs (diameter of 20 nm) at 50 mg/mL [14]. To understand
the reasons for the differences found between HUVECs and ﬁbro-
blasts we studied the mechanism of NP internalization. Cells were
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concentrations that were not cytotoxic for the cells (Supplementary
Fig. 2A), after which, ﬂuorescently labeled NPs (SNP5eDexOxAmB
and SNP5eDexOx) were added and the internalization monitored
by ﬂow cytometry. Filipin III inhibits cholesterol dependent inter-
nalization mechanisms [19], nocodazole inhibits microtubule
dependent pathways [20], cytochalasin D inhibits all pathways
dependent on actin [21], dansylcadaverine inhibits clathrin-
mediated endocytosis [22] and polyinosinic acid inhibits scav-
enger receptors [23]. Whenever possible molecules that enter by a
speciﬁc internalization pathway were used as positive controls to
show the efﬁcacy of our inhibitors (Supplementary Fig. 2B). In
HUVECs, the response to the inhibitors was similar for both types of
NPs (Fig. 2A). Actin ﬁlaments mediated the pathway with most
impact in the internalization of NPs, since cells inhibited with
cytochalasin D had no signiﬁcant NP internalization. Actin ﬁla-
ments have been shown to be implicated in the mechanisms of
clathrin-mediated endocytosis as well as macropinocytosis and
formation of circular dorsal rufﬂes [24]. Our results suggest that
macropinocytosis might be the pathway with the highest impact in
SNPs internalization since the effect of dansylcadaverine (clathrin
inhibitor) was relatively low in NP internalization. In addition,
nocodazole had an important inhibitory effect on the internaliza-
tion of both NPs, implicating microtubules in the uptake mecha-
nism. This agrees with the previous description of microtubules as
participants in the mechanism of macropinocytosis [24]. In ﬁbro-
blasts, cells do not internalize SNP5eDexOxAmB during 5 h but do
SNP5eDexOx (Supplementary Fig. 2C). In this last case, the inhib-
itory effect of cytochalasin D is similar to the effect of nocodazole,
polyinosinic acid and dansylcadaverine, which indicates that
macropinocytosis is not the pathway with the highest impact in
SNPs internalization. Overall, our results suggest that macro-
pinocytosis seems to be the main internalization route for NPs in
HUVEC but not in ﬁbroblasts. Recent studies indicate that HUVECs
can internalize carbon nanotubes coated with DNA [25] as well as
silicon microparticles [26] by macropinocytosis which indicates
that this internalization pathway is not speciﬁc for SNPs. The dif-
ferences in NP internalization on HUVECs and ﬁbroblasts might
thus be related to differences in macropinocytosis among cells.
Because the internalization of the NPs by macropinocytosis
might be related to the aggregation of the NPs, we studied the size
and stability of SNP5eDexOx and SNP5eDexOxAmB in HUVEC
culture media (EGM-2 containing 2% FBS) or ﬁbroblast culture
medium (DMEM containing 10% FBS) by dynamic light scattering
(Supplementary Fig. 3). For concentrations of 10 mg/mL, the number
of NP counts was very low (below 100 kcps) and therefore not
evaluated. For concentrations between 50 and 300 mg/mL NPs
aggregate followed by sedimentation. The aggregation and sedi-
mentation kinetics depend on the initial concentration of the NPs,
type of NP and culture medium. Therefore, it is possible that the
aggregation of the NPs contribute for the internalization mecha-
nism through macropinocytosis in HUVECs. Overall, our results
indicate that HUVECs internalize higher amounts of SNPs, partic-
ularly SNP5eDexOxAmB, than ﬁbroblasts and this is likely
explained by the fact that HUVECs are more prone to macro-
pinocytosis than ﬁbroblasts.
3.3. Intracellular accumulation of SNPs conjugated with and
without AmB
Confocal microscopy was performed to conﬁrm that SNPs were
located intracellularly rather than adsorbing onto the cell surface
and to identify the exact intracellular location following internali-
zation. For this purpose, cells were exposed for 5 and 24 h to ﬂu-
orescently labeled SNPs (50 mg of NPs per mL of medium).Endolysosomes were stained with Lysotracker Red DND-99 and cell
membrane stained with anti-human CD31 (for HUVECs; for ﬁbro-
blasts no marker was used) (Fig. 2 and Supplementary Fig. 4). Im-
ages of cells reconstructed from z-stacks of confocal images
indicated extensive cellular uptake of NPs, mainly in HUVECs. For
both types of cells, after 5 h of exposure, NPs aremainly observed in
the periphery of the cell. At 24 h, the NPs were in general localized
in the perinuclear region. This agrees with other reports showing
perinuclear accumulation of silica-based nanoparticles in different
type of cells [27]. Furthermore, our results show that a signiﬁcant
percentage (HUVECs (24 h)-SNP5eDexOx: 77.6  15.7%; SNP5e
DexOxAmB: 99.1  0.8%; Fibroblasts (24 h)-SNP5eDexOx:
75.9  34.0%; SNP5eDexOxAmB: 94.1  8.3%) of the NPs were
localized in endolysosomes as shown by the co-localization of the
NPs with the lysotracker staining (Fig. 2B). We further character-
ized the cellular uptake of SNPs in HUVECs by transmission electron
microscopy (TEM) analyses (Fig. 3). TEM results conﬁrm that either
SNP5eDexOx or SNP5eDexOxAmB are taken up by HUVECs and
localize within endolysosomal vesicles. Our results also indicate
that NPs are taken up by macropinocytosis, with large membrane
rufﬂes engulﬁng aggregates of NPs (Fig. 3 A.1 and B.2). Overall, our
results indicate that most of the NPs that are taken up by both types
of cells accumulate in endolysosomal vesicles.
3.4. Susceptibility of HUVECs and ﬁbroblasts to the cytotoxic effect
of SNPs conjugated with AmB
Previous studies have reported that AmB conjugated to carbon
nanotubes had relatively small toxicity towards Jurkat cells, derived
from a human T-cell leukemia [5,6]. The cells were incubated up to
16 h with AmB conjugated to carbon nanotubes (10 mg/mL). At the
end, only 7% of the cells were apoptotic and 6% necrotic. However,
the concentration of nanotubes within the cells was not quantiﬁed
and this is important for the evaluation of the cytotoxicity proﬁle of
the AmB conjugate. Furthermore, the effect of AmB conjugates on
other cell types is still unclear. Although a cell line (such as Jurkat
cells) is highly valuable to address questions regarding cytotoxicity,
the results should be validated with primary cells [6]. Studies with
NPs of different chemical composition suggest that cancer cells are
more resistant to NP-mediated toxicity than primary cells found in
the human body [14,17].
To assess the biological effect of NPs, cell metabolism and cell
proliferation was evaluated after exposing ﬁbroblasts and HUVECs
to various concentrations of NPs (from 10 to 500 mg/mL) for 5 h and
24 h (Fig. 4). Cell metabolism was assessed by ATP production.
Small effect (between 10% and 20%) in ATP production was
observed for both type of cells exposed to the NPs for 5 h. However,
HUVECs exposed to concentrations equal or higher than 50 mg/mL
of SNP5eNH2 (50 mg/mL: 62.3  10.7% of ATP production relatively
to control; 100 mg/mL: 5.5  5.2%) for 24 h showed signiﬁcant
impaired ATP production. Similar ﬁndings have been reported in a
previous study for positively charged silica nanotubes with 200 nm
in length [28]. The nanotubes were cytotoxic for concentrations of
0.5 mg/mL against HUVECs. Here, HUVECs exposed to SNP5eDexOx
(50 mg/mL: 92.0  14.6%, relative to control; 100 mg/mL:
75.5  23.7%) present signiﬁcantly less impairment in ATP pro-
duction (P< 0.0001, n ¼ 6) than cells exposed to SNP5eDexOxAmB
(50 mg/mL: 45.110.3%; 100 mg/mL: 29.8 6.4%) for concentrations
equal or above 50 mg/mL, during 24 h. The effect of NP in cell
proliferation was also evaluated. Fibroblast proliferation was not
substantially affected in medium containing SNPs up to a concen-
tration of 100 mg/mL (Fig. 4C.2). In contrast, HUVEC proliferation
was affected in medium containing SNP5eDexOx or SNP5eDex-
OxAmB, being highly affected in the last case (Fig. 4C.1). Overall, the
results of metabolism and cell proliferation indicate that HUVECs
Fig. 2. Internalization mechanism and intracellular localization of NPs. A) Uptake of SNP5eDexOxAmB (A.1) and SNP5eDexOx (A.2) by HUVECs in the presence of several
endocytosis inhibitors. The results are expressed as Mean  SEM (n ¼ 3). B) Intracellular localization of NPs as assessed by confocal microscopy. Cells were incubated with
ﬂuorescent SNP5eDexOx or ﬂuorescent SNP5eDexOxAmB (50 mg/mL) for 5 or 24 h. After incubation the cells were washed to remove NPs not taken up by cells, the endosomes, cell
membrane and nuclei were stained with Lysotracker Red DND-99, anti-human CD31 and DAPI, respectively. Bar corresponds to 20 mm.
C.S.O. Paulo et al. / Biomaterials 34 (2013) 5281e52935286are more sensitive to SNPs than ﬁbroblasts. In addition, HUVECs are
more sensitive to SNP5eDexOxAmB than SNP5eDexOx indicating
that AmB presented by the NPs is cytotoxic.
To determine whether the results obtained by cell metabolism
were due to cell death,we exposedHUVECs to SNPs for 5,12 and 24 h
and quantiﬁed cell viability/necrosis/apoptosis by ﬂow cytometry
using annexin V/PI staining (Fig. 5A). Annexin V is a phospholipid-binding protein with speciﬁcity for phosphatidyl serine, one of the
earliest markers of cellular transition to an apoptotic state. This
phospholipid is translocated from the inner to outer leaﬂet of the
plasma membrane [29]. PI enters necrotic cells and binds to double-
stranded nucleic acids, but is excluded from cells with normal
integrity [30]. According to Fig. 5A, the viability of HUVECs cultured
in medium containing 10 mg/mL of SNP5eDexOxAmB for up to 24 h
Fig. 3. Intracellular localization of NPs as evaluated by TEM. HUVECs were incubated with SNP5eDexOxAmB (50 mg/mL) (A) or SNP5eDexOx (50 mg/mL) (B) for 24 h. The ar-
rowheads indicate the presence of endolysosomal compartments. Arrow indicates the presence of sites of NP internalization. Bar corresponds to 1 mm.
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(necrosis ofw2%; apoptosis ofw10%). However, HUVECs cultured in
medium with 50 and 300 mg/mL of SNP5eDexOxAmB show signif-
icant levels of necrosis at 5 h (50 mg/mL: 5.1  2.6%; 300 mg/mL:
61.6  3.5%) and 24 h (50 mg/mL: 14.7  2.7%; 300 mg/mL:
29.7  4.0%), as compared to cells cultured without NPs. This effect
was signiﬁcantly reduced when HUVECs incubated with NPs
(300 mg/mL) were inhibited with cytochalasin D (macropinocytosis
inhibitor, see above) for 5 h (Supplementary Fig.1 B). Importantly, for
the same concentration, the cellular necrosis was approximately
two- or three-fold higher than the one observed on SNP5eDexOx
(without AmB), showing that AmB is important in the cytotoxicity
proﬁle observed. In contrast to cell necrosis, cell apoptosis was in-
dependent of NP concentration. The levels of cell apoptosis (early
and late apoptosis) ﬂuctuated along the different concentrations
tested, being in most cases below 20%. These results indicate that
necrosis and not apoptosis is the predominant death pathway.
To investigate whether cell death is mediated by loss of cell
membrane integrity, lactate dehydrogenase (LDH) leakage was
measured (Fig. 5B). HUVECs cultured with SNP5eDexOx (without
AmB) up to 300 mg/mL show minimal LDH leakage over 24 h. In
contrast, HUVECs cultured in medium containing SNP5eDexOx-
AmB show high LDH leakage at 5 (300 mg/mL) and 24 h (concen-
trations 50,100 and 300 mg/mL). Overall, our results suggest that for
low concentrations of SNP5eDexOxAmB (up to 100 mg/mL) the
NPs are internalized by the cell and only after they contribute for
the loss of cell membrane integrity. For high concentrations
(300 mg/mL), the overlap between NP internalization and LDH
leakage for 5 h makes it difﬁcult to interpret the results. However,
the reduction, but not elimination of observed necrosis for HUVECs
cultured in the presence of high concentrations of NPs and cyto-
chalasin D (which completely inhibits NP internalization, see
above) indicates that the NPsmay also exert a direct cytotoxic effect
on the cell membrane.
Overall, our results indicate that HUVECs were more susceptible
than ﬁbroblasts to the cytotoxic effect of NPs. This was evaluated by4 different methodologies: cell metabolism by ATP measurements,
cell viability by annexin V/PI staining, cell proliferation and cell
membrane integrity by LDHmeasurements. HUVECs were sensitive
to concentrations of 50 mg/mL SNP5eDexOxAmB (at this concen-
tration, no substantial cytotoxic effect was observed for SNP5e
DexOx) while ﬁbroblasts were resistant to concentrations up to
500 mg/mL of SNP5eDexOxAmB. The low cytotoxicity in ﬁbroblasts
is partially due to their low ability to internalize NPs. However, this
does not explain all the results since HUVECs inhibited with cyto-
chalasin D (macropinocytosis inhibitor) show cell death (35%) after
5 h of exposure to 300 mg/mL of SNP5eDexAmB (not observed in
ﬁbroblasts). Therefore, it is likely that differences in the cell
membrane composition between HUVECs and ﬁbroblasts might
account also for the differences between endothelial and ﬁbroblast
cells. The differences in toxicity of soluble AmB between HUVEC
and ﬁbroblasts support this hypothesis (Supplementary Fig. 5). Our
results show that ﬁbroblasts are less sensitive to soluble AmB than
HUVECs. Importantly, the cytotoxic effect of SNP5eDexOxAmB
against HUVECs was dependent on its concentration: low concen-
trations of NPs (up to 100 mg/mL) were ﬁrstly internalized before
inducing any cytotoxicity, while high concentrations of NPs (above
100 mg/mL) induce a rapid cytotoxicity (observed at 5 h) likely not
mediated by NP internalization. Further, our results show that SNPs
conjugated with AmB are more cytotoxic against HUVECs than
SNPs without AmB. The results obtained by LDH measurements
highlight signiﬁcant differences in the cytotoxic effect of both NPs.
While SNP5eDexOxAmB induce cellular LDH leakage, SNP5e
DexOx does not have the same effect. This shows that part of the
cytotoxic mechanism of AmB in the SNPs is related to its interfer-
ence with cell membrane integrity.
3.5. Assessment of oxidative stress in cells cultured with SNPs
conjugated with and without AmB
Previous studies have reported that the cytotoxicity of SNPs is
associated with increased oxidative stress. Studies in HUVECs have
Fig. 4. Effect of NPs on cell metabolism and proliferation. (A) The cytotoxicity of NPs was evaluated by cell metabolism. HUVECs (A.1 and A.2) or ﬁbroblasts (B.1 and B.2) were
incubated with SNP5eNH2, SNP5eDexOx or SNP5eDexOxAmB for 5 h (A.1 and B.1) or 24 h (A.2 and B.2). In A and B, the results are expressed as Mean  SEM (n ¼ 6). *, ** and ***
denote statistical signiﬁcance (P < 0.05, P < 0.01, P < 0.001, respectively). (C) Quantiﬁcation of cell number of HUVECs (C.1) or ﬁbroblasts (C.2) incubated with SNP5eDexOx or
SNP5eDexOxAmB for 24 h. Results are expressed as Mean  SEM (n ¼ 3). TCPS means cells cultured in tissue culture polystyrene.
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oxygen species (ROS) production, which in turn induce apoptosis,
via JNK, p53 and NF-kB pathways [14]. Furthermore, it has been
suggested that AmB increases cellular oxidative stress, speciﬁcally
lipid peroxidation [2]. To establish the role of oxidative stress in the
cytotoxicity of SNPs, carboxy-H2DCFDA staining was performed
and evaluated by ﬂow cytometry (Fig. 5C). In the presence of
reactive oxygen species (ROS) ﬂuorescence intensity of the cells
stained with this dye increases. HUVECs exposed to SNP5eDexOx
give rise to ROS, which increase as a function of SNP intracellularconcentration (for 5 and 24 h). In contrast, the effect of SNP5e
DexOxAmB in HUVECs was dependent on its concentration. For
small concentrations of SNP5eDexOxAmB (up to 50 mg/mL) there is
production of ROS, while for high concentrations (300 mg/mL) no
substantial ROS are produced. These results agree with the two-
dose dependent effect of SNP5eDexOxAmB described before: low
concentrations (up to 50 mg/mL) are internalized by HUVECs and
induce ROS production while high concentrations (300 mg/mL)
induce cell membrane damage even in the absence of cell inter-
nalization and ROS production.
Fig. 5. Effects of NPs on cell viability, LDH leakage and ROS production. (A) Cell viability as assessed by annexin V/PI staining. The percentage of apoptotic and necrotic cells was
determined by ﬂow cytometry after incubation of HUVEC for 5 h (A.1) or 24 h (A.2) with: a: no NPs (negative control), b: SNP5eDexOx (0.01 mg/mL), c: SNP5eDexOxAmB (0.01 mg/
mL), d: SNP5eDexOx (0.05 mg/mL), e: SNP5eDexOxAmB (0.05 mg/mL), f: SNP5eDexOx (0.3 mg/mL), g: SNP5eDexOxAmB (0.3 mg/mL) and h: positive control for apoptosis (cells
incubated with 15.3 mg/mL of AmB for 5 h). Percentages of live (annexin V/PI), early apoptotic (annexin Vþ/PI), late apoptotic (annexin Vþ/PIþ) and necrotic (annexin V/PIþ)
cells were obtained. Results are expressed as Mean  SEM (n ¼ 3). (B) LDH release from HUVECs to the medium at 5 h (B.1) and 24 h (B.2). Results are expressed as Mean  SEM
(n ¼ 6). Triton X-100 was used as positive control at 24 h being the LDH release of 1024.2%  69.9 relatively to control (data not shown in the graph for simplicity). (C) ROS
production by HUVECs exposed to NPs for 12 h (C.1) and 24 h (C.2). ROS was detected by ﬂow cytometry analysis using the oxidation-sensitive probe carboxy-H2DCFDA. Results are
expressed as Mean  SEM (n ¼ 3). In all graphs, *, ** and *** denote statistical signiﬁcance (P < 0.05, P < 0.01, P < 0.001, respectively).
C.S.O. Paulo et al. / Biomaterials 34 (2013) 5281e5293 5289
C.S.O. Paulo et al. / Biomaterials 34 (2013) 5281e529352903.6. Expression of pro-inﬂammatory cytokines by cells treated with
SNPs conjugated with and without AmB
Studies in HUVECs have shown that SNPs induce the release of
tissue factor, IL-6, IL-8 and MCP-1 [14]. Furthermore, it has been
demonstrated that patients that received AmB have an induction of
TNF-a, IL-6, IL-1RA and IL-1b [31]. In addition, human innate im-
mune cells cultured with AmB produce high levels of inﬂammatory
cytokines (TNF-a, IL-6, IL-1RA and IL-1b) and chemokines (IL-8,
monocyte chemotactic protein-1 and macrophage inﬂammatory
protein-1b) [32,33]. To evaluate inﬂammatory response and
endothelial/ﬁbroblast activation induced by SNPs, HUVECs or ﬁ-
broblasts were exposed to the NPs (50 mg/mL) for 5 and 24 h. The
collected cell mediumwas then characterized for the presence of 17Fig. 6. Effects of NPs on cell secretome and transcriptome. (A) Analysis of cytokines secreted
for 5 or 24 h. Mean  SEM (n ¼ 3). * (P < 0.05) and ** (P < 0.01) denote statistical signiﬁcance
statistical signiﬁcance between SNP5eDexOxAmB and SNP5eDexOx. (B) Stress gene analysis
and B, cells incubated in the absence of SNPs were used as control.different cytokines using a cytokine bead array (Fig. 6A). For
HUVECs and ﬁbroblasts only 4 (MCP-1, IL-8, IL-6 and G-CSF) and 3
(IL-8, IL-6 and MCP-1) cytokines were measurable, respectively. At
5 h, no signiﬁcant difference (P > 0.05, n ¼ 4) was observed for all
the groups tested, i.e., untreated cells (i.e., cells not exposed to NPs)
and cells treated with SNP5eDexOx or SNP5eDexOxAmB. At 24 h,
HUVECs exposed to SNP5eDexOxAmB secreted signiﬁcantly higher
levels of IL-8, IL-6 and G-CSF than untreated HUVECs and IL-6 and
G-CSF than HUVECs exposed to SNP5eDexOx. Yet, the differences
observed in cells treated with SNP5eDexOxAmB and SNP5eDexOx
were relatively low. In case of ﬁbroblasts (time 24 h), cells secreted
similar levels of IL-6 and MCP-1 in all the experimental groups
tested, but lower levels of IL-8 when treated with SNP5eDexOx-
AmB than in control (P < 0.01, n ¼ 4).by HUVECs of ﬁbroblasts incubated with SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL)
between SNP5eDexOxAmB and control while ##(P < 0.01) and ###(P < 0.001) denote
of HUVECs incubated with SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL) for 24 h. In A
Fig. 7. HUVECs incubated with SNP5eDexOxAmB highly express HSP70. (A) Expression and localization of HSP70 as evaluated by confocal imaging. HUVECs were incubated with
ﬂuorescent SNP5eDexOx or SNP5eDexOxAmB (50 mg/mL) for 5 h. Cells were stained with a HSP70 antibody and cell nuclei was stained with DAPI. HUVEC subjected to heat stress
were incubated at 42.5 C for 3 h. Scale bar corresponds to 20 mm. (B) Quantiﬁcation of total HSP70 by an ELISA assay. HUVECs were incubated with SNP5eDexOx or SNP5e
DexOxAmB (50 mg/mL) for 5 or 24 h. The results were normalized relative to cells cultured without NPs. Results are expressed as Mean  SEM (n ¼ 3). *, *** denote statistical
signiﬁcance (P < 0.05, P < 0.001).
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SNPs conjugated with and without AmB
To further investigate the cytotoxic effect of SNPs in HUVECs,
microarray studies (an array of 90 genes involved in cell apoptosis/
necrosis) were performed to identify differentially expressed genes
that may be responsible for the observed cytotoxic proﬁle (Fig. 6B).
In some cases, gene expression observed in HUVECs exposed to
SNP5eDexOx or SNP5eDexOxAmB was similar, and therefore not
related to the presence of AmB. For example, in both cases, HUVECs
have a downregulation of genes related to cell proliferation, and an
upregulation of genes involved in cell arrest and senescence. This
agrees with previous studies showing that cells exposed to certain
concentrations of silver NPs [34], gold-based NPs [35], chitosan-
based NPs [36], titanium dioxide NPs [37], or gold nanorods [38]
have an arrest in cell proliferation (decrease in G1 population
accompanied by an increase in G2/M population). In addition, our
results show that HUVECs exposed to NPs have impaired DNA
repair mechanisms as compared to untreated cells (cells not
exposed to NPs). Only 1 out of 11 genes involved in DNA repair was
upregulated in HUVECs exposed to NPs, while in untreated cells 9
out of 11 genes were upregulated (Fig. 6B). The DNA repair ma-
chinery involves enzymes, which require energy from ATP to
remodel the chromatin [27,39]. Therefore, the decrease of ATP in
HUVECs exposed to NPs (Fig. 4) likely affected the enzyme-
mediated DNA repair mechanisms, as well as the cascade of
events requiring phosphorylation of proteins taking part in the
repair of DNA [40]. Moreover, our results show that HUVECs
exposed to NPs are more prone to oxidative and metabolic stress.
This corroborates previous data showing that SNPs induce oxida-
tive stress in several types of cells [41]. This is likely due to the
generation of ROS by SNPs.
Gene arrays revealed signiﬁcant differences between HUVECs
exposed to SNP5eDexOxAmB and SNP5eDexOx in the clusters of
genes involved in inﬂammation and heat shock response (Fig. 6B).
HUVECs exposed to SNP5eDexOxAmB are more prone to induce
inﬂammation since 10 out of 14 genes are upregulated. In contrast,
in HUVECs exposed to SNP5eDexOx only 1 out of 14 genes is
upregulated. From all the genes upregulated in cells exposed to
SNP5eDexOxAmB, chemokine (CeC motif) ligand 4 (CCL4), also
known as macrophage inﬂammatory protein 1 b (MIP-1b), IL-1b
and CSF2, also known as granulocyte macrophage colony-
stimulating factor (GM-CSF), were not observed at protein level
(by the cytokine bead array) which may indicate that the concen-
tration secreted was too low (below 1 pg/mL) and therefore out of
the sensitivity range of the analysis performed, or the genes were
not expressed at protein level.
HUVECs exposed to SNP5eDexOxAmB and SNP5eDexOx
showed a different proﬁle of expression of genes related to heat
shock proteins (Fig. 6B). HUVECs exposed to SNP5eDexOxAmB
showed higher expression of genes related to heat shock proteins
than cells exposed to SNP5eDexOx. Some of the genes identiﬁed in
our array encodemembers of the heat shock protein 10 (HSPE1), 60
(HSPD1), 90 (HSP90AB1; HSP90AA2) and 100 (HSPH1). However,
most of the genes encode members of the heat shock protein 70,
namely protein 1A (HSPA1A), protein 1L (HSPA1L), protein 2
(HSPA2), protein 5 (HSPA5), protein 6 (HSPA6) and protein 8
(HSPA8). HSP70 is found in the nucleus and cytoplasm and its role is
to help in the folding of nascent proteins and avoid the accumu-
lation of misfolded proteins [42]. This protein is the only one of the
family whose transcription is not constitutive, but is highly
inducible by high temperatures [43]. Therefore, we used immu-
noﬂuorescence to monitor the expression and subcellular locali-
zation of HSP70 in cells incubated with SNP5eDexOx or SNP5e
DexOxAmB (50 mg/mL, for 5 or 24 h) (Fig. 7A). The antibodyrecognizes several members of the heat shock protein 70 kDa
(Hsp70) gene family including Hsp70, Hsc70 and p75. Cells without
exposure to SNPs or heat stress have a diffuse distribution of HSP70
at the cytoplasm, and at less extent in the nucleus. In contrast, cells
exposed to a heat shock at 42.5 C for 3 h have an overall increase in
the intensity of ﬂuorescence due to the induced synthesis of HSP70
and an increase in the nuclear localization of HSP70 protein pri-
marily in the phase-dense nucleolar structures. Likewise, cells
cultured with SNP5eDexOx or SNP5eDexOxAmB for 5 h have an
increase in the ﬂuorescence intensity and a nuclear localization of
HSP70. At 24 h (Supplementary Fig. 6), there is an increase in the
ﬂuorescence intensity and nuclear localization of HSP. In this case,
spots of HSP70 were also observed at the cell cytoplasm.
The temporal pattern of total HSP70 expression was conﬁrmed
quantitatively by an ELISA assay (Fig. 7B). HUVECs exposed to a heat
shock have a 6-fold increase in HSP70 content. HUVECs treated
with SNP5eDexOx have a slight increase in the expression of
HSP70, although not statistically different from the control
(P > 0.05, n ¼ 3). Importantly, HUVECs treated with SNP5eDex-
OxAmB have a 2-fold increase in HSP70 content relatively to control
at 24 h, and the content is statistically different (P< 0.001, n¼ 3) to
cells exposed to SNP5eDexOx.
Although heat stress is the classic inducer of heat shock pro-
teins, a variety of other stresses including pesticides, heavy metals,
and solvents can induce heat shock proteins. Among the various
HSP isoforms, HSP70 is often the most representative HSP protein
to be expressed following environmental stresses. Indeed the
expression of HSP70 has been used as a tool to evaluate the level of
toxicity in cells to certain chemicals. However, with the exception
of few studies with silver NPs, HSP70 has not been connected with
nanotoxicity [43,44]. HSP70 is a molecular chaperone that binds to
exposed hydrophobic segments of unfolded proteins preventing
the formation of protein aggregates and facilitating spontaneous
native-protein folding [45]. This protein moves to the nucleus in
response to stress. It is believed that the nuclear localization of
HSP70 is related to the preservation of ribosomal assembly and
function [46]. The increase in the expression of HSP70 in HUVECs
treated with SNP5eDexOxAmB as compared to the ones treated
with SNP5eDexOx indicates higher stress and protein unfolding.4. Conclusions
Our study demonstrates that the biological impact of AmB
immobilized on NPs depends on the cell type. NPs conjugated with
AmB are highly internalized by HUVECs but not ﬁbroblasts. Further,
the internalization after 24 h is higher for HUVECs exposed to NPs
conjugated with AmB than without AmB. The internalization pro-
cess in HUVECs is mainly mediated by macropinocytosis, while in
ﬁbroblasts the internalization is mediated by different pathways. In
both type of cells, the NPs accumulate primarily in the endolyso-
somal compartment. Our study also demonstrates that the cyto-
toxic proﬁle of NPs conjugatedwith AmB is negligible on ﬁbroblasts
for concentrations up to 400 mg/mLwhile for HUVECs depend in the
NP concentration. For concentrations of SNP5eDexOxAmB up to
10 mg/mL they are non-cytotoxic. For concentrations between 10
and 100 mg/mL the cytotoxic effect is mediated by the production of
ROS. There is (i) cell death (approximately 70% of the initial cells
after 24 h for a concentration of 50 mg/mL), (ii) LDH release after
24 h of exposure to NPs, (iii) high expression of pro-inﬂammatory
cytokines and chemokines (IL-8, IL-6, G-CSF, CCL4, IL-1b and
CSF2), (iv) high expression of genes related to heat shock proteins,
and (v) an increase in the expression of HSP70 at protein level. For
concentrations of SNP5eDexOxAmB above 100 mg/mL the cytotoxic
effect is mediated by cell permeabilization. This is conﬁrmed by the
C.S.O. Paulo et al. / Biomaterials 34 (2013) 5281e5293 5293absence of ROS and an increase in the release of LDH. Sixty percent
of the initial cells are dead after 5 h.
Acknowledgments
The authors would like to thank the ﬁnancial support of Fun-
dação para a Ciência e a Tecnologia (SFRH/BD/35270/2007;
fellowship to C. P.; PTDC/Qui-Qui/105000/2008), Matera [QREN
(project n5402)] and the MIT-Portugal Program (focus in Bioen-
gineering). The authors would like to thank Mario Grãos (Biocant)
for the cytokine analyses, Olga Borges and Sandra Jesus (both from
the Center for Neuroscience and Cell Biology) in the detection of
endotoxin levels in the NPs.
Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.biomaterials.2013.03.048.
References
[1] Torrado JJ, Espada R, Ballesteros MP, Torrado-Santiago S. Amphotericin B
formulations and drug targeting. J Pharm Sci 2008;97:2405e25.
[2] Brajtburg J, Powderly WG, Kobayashi GS, Medoff G. Amphotericin B: current
understanding of mechanisms of action. Antimicrob Agents Chemother
1990;34:183e8.
[3] Hudson SP, Langer R, Fink GR, Kohane DS. Injectable in situ cross-linking
hydrogels for local antifungal therapy. Biomaterials 2010;31:1444e52.
[4] Zumbuehl A, Ferreira L, Kuhn D, Astashkina A, Long L, Yeo Y, et al. Antifungal
hydrogels. Proc Natl Acad Sci U S A 2007;104:12994e8.
[5] Wu W, Wieckowski S, Pastorin G, Benincasa M, Klumpp C, Briand JP, et al.
Targeted delivery of amphotericin B to cells by using functionalized carbon
nanotubes. Angew Chem Int Ed Engl 2005;44:6358e62.
[6] Benincasa M, Pacor S, Wu W, Prato M, Bianco A, Gennaro R. Antifungal activity
of amphotericin B conjugated to carbon nanotubes. ACS Nano 2011;5:199e208.
[7] Paulo CS, Vidal M, Ferreira LS. Antifungal nanoparticles and surfaces. Bio-
macromolecules 2010;11:2810e7.
[8] Wasan KM, Rosenblum MG, Cheung L, Lopez-Berestein G. Inﬂuence of lipo-
proteins on renal cytotoxicity and antifungal activity of amphotericin B.
Antimicrob Agents Chemother 1994;38:223e7.
[9] Wasan KM, Conklin JS. Enhanced amphotericin B nephrotoxicity in intensive
care patients with elevated levels of low-density lipoprotein cholesterol. Clin
Infect Dis 1997;24:78e80.
[10] Meletiadis J, Chanock S, Walsh TJ. Deﬁning targets for investigating the
pharmacogenomics of adverse drug reactions to antifungal agents. Pharma-
cogenomics 2008;9:561e84.
[11] Hsu S, Burnette RR. Characterization of the effects of amphotericin B on ion
channels in MDCK cells using the patch-clamp technique. Biochim Biophys
Acta 1997;1329:26e38.
[12] Brito LA, Singh M. Acceptable levels of endotoxin in vaccine formulations
during preclinical research. J Pharm Sci 2011;100:34e7.
[13] McNeer NA, Chin JY, Schleifman EB, Fields RJ, Glazer PM, Saltzman WM.
Nanoparticles deliver triplex-forming PNAs for site-speciﬁc genomic recombi-
nation in CD34þ human hematopoietic progenitors. Mol Ther 2011;19:172e80.
[14] Liu X, Sun J. Endothelial cells dysfunction induced by silica nanoparticles
through oxidative stress via JNK/P53 and NF-kappaB pathways. Biomaterials
2010;31:8198e209.
[15] Ehrenfreund-Kleinman T, Azzam T, Falk R, Polacheck I, Golenser J, Domb AJ.
Synthesis and characterization of novel water soluble amphotericin B-arabi-
nogalactan conjugates. Biomaterials 2002;23:1327e35.
[16] Shields R, Burnett W. Determination of protein-bound carbohydrate in serum
by a modiﬁed anthrone method. Anal Chem 1960;32:885e6.
[17] Chang JS, Chang KL, Hwang DF, Kong ZL. In vitro cytotoxicitiy of silica nano-
particles at high concentrations strongly depends on the metabolic activity
type of the cell line. Environ Sci Technol 2007;41:2064e8.
[18] Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M,
et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in
human endothelial cells. Small 2009;5:846e53.
[19] Kaiser RA, Oxhorn BC, Andrews G, Buxton ILO. Functional compartmentation
of endothelial P2Y receptor signaling. Circ Res 2002;91:292e9.[20] dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. Effects of transport in-
hibitors on the cellular uptake of carboxylated polystyrene nanoparticles in
different cell lines. PLoS One 2011;6:10.
[21] Fujimoto LM, Roth R, Heuser JE, Schmid SL. Actin assembly plays a variable,
but not obligatory role in receptor-mediated endocytosis in mammalian cells.
Trafﬁc 2000;1:161e71.
[22] Lunov O, Syrovets T, Loos C, Beil J, Delecher M, Tron K, et al. Differential uptake
of functionalized polystyrene nanoparticles by human macrophages and a
monocytic cell line. ACS Nano 2011;5:1657e69.
[23] Adachi H, Tsujimoto M, Arai H, Inoue K. Expression cloning of a novel scavenger
receptor from human endothelial cells. J Biol Chem 1997;272:31217e20.
[24] Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem
2009:857e902.
[25] Bhattacharya S, Roxbury D, Gong X, Mukhopadhyay D, Jagota A. DNA conju-
gated SWCNTs enter endothelial cells via Rac1 mediated macropinocytosis.
Nano Lett 2012;12:1826e30.
[26] Serda RE, Gu J, Bhavane RC, Liu X, Chiappini C, Decuzzi P, et al. The association
of silicon microparticles with endothelial cells in drug delivery to the
vasculature. Biomaterials 2009;30:2440e8.
[27] Bale SS, Kwon SJ, Shah DA, Banerjee A, Dordick JS, Kane RS. Nanoparticle-
mediated cytoplasmic delivery of proteins to target cellular machinery. ACS
Nano 2010;4:1493e500.
[28] Nan A, Bai X, Son SJ, Lee SB, Ghandehari H. Cellular uptake and cytotoxicity of
silica nanotubes. Nano Lett 2008;8:2150e4.
[29] Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van
Oers MH. Annexin V for ﬂow cytometric detection of phosphatidylserine
expression on B cells undergoing apoptosis. Blood 1994;84:1415e20.
[30] Waring MJ. Complex formation between ethidium bromide and nucleic acids.
J Mol Biol 1965;13:269e82.
[31] Arning M, Kliche KO, Heer-Sonderhoff AH, Wehmeier A. Infusion-related
toxicity of three different amphotericin B formulations and its relation to
cytokine plasma levels. Mycoses 1995;38:459e65.
[32] Rogers PD, Pearson MM, Cleary JD, Sullivan DC, Chapman SW. Differential
expression of genes encoding immunomodulatory proteins in response to
amphotericin B in human mononuclear cells identiﬁed by cDNA microarray
analysis. J Antimicrob Chemother 2002;50:811e7.
[33] Simitsopoulou M, Roilides E, Dotis J, Dalakiouridou M, Dudkova F,
Andreadou E, et al. Differential expression of cytokines and chemokines in
human monocytes induced by lipid formulations of amphotericin B. Anti-
microb Agents Chemother 2005;49:1397e403.
[34] AshaRani PV, Low Kah Mun G, Hande MP, Valiyaveettil S. Cytotoxicity and
genotoxicity of silver nanoparticles in human cells. ACS Nano 2009;3:279e90.
[35] Roa W, Zhang X, Guo L, Shaw A, Hu X, Xiong Y, et al. Gold nanoparticle
sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle.
Nanotechnology 2009;20.
[36] Luo H, Su H, Wang X, Wang L, Li J. N-Succinyl-chitosan nanoparticles induced
mitochondria-dependent apoptosis in K562. Mol Cell Probes 2012;26:164e9.
[37] Wu J, Sun J, Xue Y. Involvement of JNK and P53 activation in G2/M cell cycle
arrest and apoptosis induced by titanium dioxide nanoparticles in neuron
cells. Toxicol Lett 2010;199:269e76.
[38] Xu W, Luo T, Li P, Zhou C, Cui D, Pang B, et al. RGD-conjugated gold nanorods
induce radiosensitization in melanoma cancer cells by downregulating
alpha(v)beta(3) expression. Int J Nanomed 2012;7:915e24.
[39] Ferreira L, Squier T, Park H, Choe H, Kohane DS, Langer R. Human embryoid
bodies containing nano- and micro-particulate delivery vehicles. Adv Mater
2008;20:2285e91.
[40] Voyta JC, Via DP, Butterﬁeld CE, Zetter BR. Identiﬁcation and isolation of
endothelial cells based on their increased uptake of acetylated-Low density
lypoprotein. J Cell Biol 1984;99:2034e40.
[41] Dutta D, Sundaram SK, Teeguarden JG, Riley BJ, Fiﬁeld LS, Jacobs JM, et al.
Adsorbed proteins inﬂuence the biological activity and molecular targeting of
nanomaterials. Toxicol Sci 2007;100:303e15.
[42] Bhattacharyya T, Karnezis AN, Murphy SP, Hoang T, Freeman BC, Phillips B,
et al. Cloning and subcellular-localization of human mitochondrial Hsp70.
J Biol Chem 1995;270:1705e10.
[43] Ahamed M, Posgai R, Gorey TJ, Nielsen M, Hussain SM, Rowe JJ. Silver nano-
particles induced heat shock protein 70, oxidative stress and apoptosis in
Drosophila melanogaster. Toxicol Appl Pharmacol 2010;242:263e9.
[44] Lim DH, Jang J, Kim S, Kang T, Lee K, Choi IH. The effects of sub-lethal con-
centrations of silver nanoparticles on inﬂammatory and stress genes in hu-
man macrophages using cDNA microarray analysis. Biomaterials 2012;33:
4690e9.
[45] Goloubinoff P, De Los Rios P. The mechanism of Hsp70 chaperones: (entropic)
pulling the models together. Trends Biochem Sci 2007;32:372e80.
[46] Welch WJ, Feramisco JR. Nuclear and nucleolar localization of the 72,000-
dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem
1984;259:4501e13.
